Evaxion to announce business update and full year 2025 financial results on March 5, 2026

Yahoo Finance Published Updated Economy
Sign in to save

Affected assets and topics

$NASDAQ UPDATE CONFERENCE REPORT

Why it matters

Evaxion A/S will release its full year 2025 financial results and provide a business update on March 5, 2026, accompanied by a conference call and webcast.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Neutral Confidence 95% How confidence is read Horizon: Short term Impact: High

Market impact analysis based on neutral sentiment with 95% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim Evaxion to announce business update and full year 2025 financial results on March 5, 2026
Affected assets NASDAQ
AI inference Neutral · 95%
Generated 2026-03-02 13:00

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
51986
Timeframe
6h

Prediction lifecycle

  • Llama 3.1 8B Instant (Groq) NASDAQ Neutral 95% 6h
    Generated 6h Excluded

    Expired: not evaluated within 7 days of its 6h timeframe elapsing

Logged at publication, scored automatically once the window closes — never edited.

Original source

COPENHAGEN, Denmark, March 2, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and report its full year 2025 financial results on Thursday March 5, 2026, before opening of the Nasdaq CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions. To join t

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on March 2, 2026. Analysis and insights provided by AnalystMarkets AI.

More of the NASDAQ narrative